Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Denise Siqueira VANNI"'
Autor:
Denise Siqueira Vanni, José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Patricia Momoyo Yoshiura Zitelli, Renato Gama Altikes, Karla Toda Oti, Mário Guimarães Pessoa, Flair José Carrilho, Claudia P Oliveira
Publikováno v:
Annals of Hepatology, Vol 28, Iss , Pp 100942- (2023)
Introduction and Objectives: Non-alcoholic fatty liver disease (NAFLD) is not an exclusive disease of obese patients. Lean and overweight patients also deal with this disease. This study aimed to analyze if there is any different NAFLD phenotype betw
Externí odkaz:
https://doaj.org/article/a8ddc660e0264ac285f110192e77e2e7
Autor:
Rommel Zambrano-Huailla, Laura Guedes, Jose Tadeu Stefano, Arthur A. Arrais de Souza, Sebastián Marciano, Erika Yvamoto, Matheus Truccolo Michalczuk, Denise Siqueira Vanni, Hernan Rodriguez, Flair Jose Carrilho, Mario Reis Alvares-da-Silva, Adrian Gadano, Marco Arrese, Adelina Lozano Miranda, Claudia P. Oliveira
Publikováno v:
Annals of Hepatology, Vol 19, Iss 6, Pp 622-626 (2020)
Introduction and aims: Several non-invasive scoring systems have been developed and validated worldwide to predict the risk of liver fibrosis in nonalcoholic fatty liver disease (NAFLD). However, information about the performance of these systems in
Externí odkaz:
https://doaj.org/article/675a47e066814f0880a0f6fbdd28d336
Autor:
Sebastião Mauro B. Duarte, José Tadeu Stefano, Lucas A. M. Franco, Roberta C. Martins, Bruna D. G. C. Moraes, Denise Frediani Barbeiro, Nathalia Oliveira, Junia Marielle Teixeira Rodrigues Neri, Bruno Cogliati, Denise Siqueira Vanni, Ester C. Sabino, Flair J. Carrilho, Claudia P. Oliveira
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 18, p 10483 (2022)
Background: Obesity is one of the main health problems in the world today, and dysbiosis seems to be one of the factors involved. The aim of this study was to examine the impact of synbiotic supplementation on obesity and the microbiota in ob/ob mice
Externí odkaz:
https://doaj.org/article/3df2cc9dab1149a590469c027c499461
Autor:
Sebastião Mauro Bezerra DUARTE, José Tadeu STEFANO, Denise Siqueira VANNI, Flair José CARRILHO, Claudia Pinto Marques Souza de OLIVEIRA
Publikováno v:
Arquivos de Gastroenterologia, Vol 56, Iss 4, Pp 431-439 (2019)
ABSTRACT The nonalcoholic fatty liver disease (NAFLD) affects approximately 20%-30% of general population and is even more prevalent among obese individuals. The risk factors mainly associated with NAFLD are diseases related to the metabolic syndrome
Externí odkaz:
https://doaj.org/article/71e69719d61442a38c377c5e039f8125
Autor:
José Tadeu Stefano, Laura Vilar Guedes, Arthur Alencar Arrais de Souza, Denise Siqueira Vanni, Venâncio Avancini Ferreira Alves, Flair José Carrilho, Alvaro Largura, Marco Arrese, Claudia P. Oliveira
Publikováno v:
Annals of Hepatology, Vol 20, Iss , Pp 100253- (2021)
Introduction/aims: Liver fibrosis assessment is a key issue in the evaluation of nonalcoholic fatty liver disease (NAFLD) patients. In the present study, we aimed to validate a noninvasive marker panel to assess significant and advanced fibrosis in t
Externí odkaz:
https://doaj.org/article/62a58131cafa43fdb1668e001af5d591
Autor:
Denise Siqueira Vanni, Bruno Horstmann, Alexandre Miguel Benjo, João Paulo Lima Daher, Salim Kanaan, Marcos Sleiman
Publikováno v:
Jornal Brasileiro de Patologia e Medicina Laboratorial, Vol 43, Iss 3, Pp 181-189 (2007)
Neste artigo faremos uma revisão bibliográfica de modo que entendamos como o óxido nítrico (NO) atua sobre as plaquetas, compreendendo assim mais um mecanismo antiplaquetário. Nos últimos 25 anos a função do NO na biologia evoluiu do seu reco
Externí odkaz:
https://doaj.org/article/4d3b45d99dc24ac0b0ddaf28264f5ac4
Autor:
Denise Siqueira Vanni, Abhijit Chowdhury, Arun J. Sanyal, Mohammed S. Siddiqui, José Tadeu Stefano, Sherry Boyett, Claudia P. Oliveira, Angelo H. Paredes, Lawrence Serfaty
Publikováno v:
Hepatoma research. 6
To compare the phenotype of lean versus overweight (OW) and obese (OB) subjects with non-alcoholic fatty liver disease (NAFLD) across multiple continents.A retrospective study of histologically defined subjects from a single center each in France (Fr
Autor:
Claudia P. Oliveira, Sebastião Mauro Bezerra Duarte, Denise Frediani Barbeiro, Bruna D. G. C. Moraes, Lucas A M Franco, Roberta Cristina Ruedas Martins, José Tadeu Stefano, Ester Cerdeira Sabino, Denise Siqueira Vanni, Flair José Carrilho, Junia Marielle Teixeira Rodrigues Neri, Nathália Lourdes Nepomuceno de Oliveira
Background: Obesity is one of the main health problems in the world today and dysbiosis seem to be one of the factors involved. The aim of this study was to examine the impact of synbiotic supplementation in obesity and microbiota in ob/ob mice. 20 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b4ce84a490d7df297594fbda4947ab
https://doi.org/10.21203/rs.3.rs-655169/v1
https://doi.org/10.21203/rs.3.rs-655169/v1
Autor:
Matheus Truccolo Michalczuk, Flair José Carrilho, Marco Arrese, Denise Siqueira Vanni, Claudia P. Oliveira, Hernan Rodriguez, Adelina Lozano Miranda, José Tadeu Stefano, Erika Yuki Yvamoto, Mário Reis Álvares-da-Silva, Laura Vilar Guedes, Sebastián Marciano, Rommel Zambrano-Huailla, Arthur Alencar Arrais de Souza, Adrián Gadano
Publikováno v:
Annals of Hepatology, Vol 19, Iss 6, Pp 622-626 (2020)
Introduction and aims Several non-invasive scoring systems have been developed and validated worldwide to predict the risk of liver fibrosis in nonalcoholic fatty liver disease (NAFLD). However, information about the performance of these systems in L
Autor:
José Tadeu Stefano, Flair José Carrilho, Denise Siqueira Vanni, Alvaro Largura, Claudia P. Oliveira, Laura Vilar Guedes, Venâncio Avancini Ferreira Alves, Arthur Alencar Arrais de Souza, Marco Arrese
Publikováno v:
Annals of Hepatology, Vol 20, Iss, Pp 100253-(2021)
Introduction/aims Liver fibrosis assessment is a key issue in the evaluation of nonalcoholic fatty liver disease (NAFLD) patients. In the present study, we aimed to validate a noninvasive marker panel to assess significant and advanced fibrosis in th